RG 14524
Latest Information Update: 17 Feb 1995
At a glance
- Originator Aventis
- Class Antiasthmatics
- Mechanism of Action Leukotriene D4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 17 Feb 1995 Discontinued-Preclinical for Asthma (Unknown route)